Abstracts Archive - Page 877 of 2607 - ACR Meeting Abstracts

Abstract Number: 0609 • ACR Convergence 2020
Impact of Depressive Symptoms, Anti-depression Treatment on Direct Medical Costs Among Medicare Beneficiaries with Knee Osteoarthritis (KOA)
Shuang Song¹, Jeffrey Katz² and Elena Losina², ¹Brigham and Women's Hospital, Brighton, MA, ²Harvard Medical School / The Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) at Brigham and Women's Hospital, Boston, MA
Background/Purpose: Depressive symptoms are prevalent among knee OA (KOA) patients and likely lead to additional medical costs. We sought to quantify the prevalence of depressive…
Abstract Number: 0610 • ACR Convergence 2020
Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak
Kent Kwas Huston¹, Nehad Soloman², Janna Radtchenko³, Simon Helfgott⁴, Jasvinder Singh⁵ and Colin Edgerton⁶, ¹Kansas City Physician Partners, Kansas City, MO, ²Arizona Arthritis & Rheumatology Associates, P.C., Peoria, AZ, ³Trio Health, Louisville, CO, ⁴BWH- HMS, Boston, MA, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶Articularis Healthcare, Summerville, SC
Background/Purpose: Patients (pts) with autoimmune diseases managed by rheumatologists represent vulnerable population with risk of serious complications if exposed to novel coronavirus SARS-CoV2. The first…
Abstract Number: 0611 • ACR Convergence 2020
Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis
Louise Thoma¹, Rebecca Cleveland², S. Louis Bridges³, Beth Jonas¹ and Leigh Callahan⁴, ¹University of North Carolina at Chapel Hill, Chapel Hill, NC, ²University of North Carolina, Chapel Hill, NC, ³University of Alabama at Birmingham, Mountain Brk, AL, ⁴University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC
Background/Purpose: Considerable advances in pharmacological care for adults with rheumatoid arthritis (RA) over the last 25 years have reduced disease activity in individual patients, but…
Abstract Number: 0612 • ACR Convergence 2020
Differences in 30-Day Rehospitalization Risk and Predictors by Age Group Among Patients with Lupus in Medicare
Maria Schletzbaum¹, Yi Chen², Ann Sheehy³, Farah Kaiksow³, Ryan Powell⁴, Andrea Gilmore-Bykovskyi⁵, Amy Kind⁶ and Christie Bartels⁷, ¹University of Wisconsin-Madison School of Medicine and Public Health, Department of Population Health Sciences, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Department of Biostatistics and Medical Informatics, Madison, WI, ³University of Wisconsin School of Medicine and Public Health, Department of Medicine, Hospital Medicine Division, Madison, WI, ⁴University of Wisconsin School of Medicine and Public Health, Department of Medicine, Geriatrics Division, Madison, WI, ⁵University of Wisconsin - Madison, School of Nursing, Madison, WI, ⁶University of Wisconsin-Madison School of Medicine and Public Health, Department of Medicine, Health Services and Care Research Program, Geriatrics Division, Madison, WI, ⁷University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI
Background/Purpose: Although our recent research demonstrates that young adult Medicare beneficiaries (age 18-35) with lupus (SLE) have higher risk of 30-day rehospitalization, predictors specific to…
Abstract Number: 0613 • ACR Convergence 2020
Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease
Kevin Kennedy¹, Emily Sirotich², Salman Surangiwala³, Maggie Larche², Mitchell Levine¹ and Jonathan Hausmann⁴, ¹McMaster University, Hamilton, Canada, ²McMaster University, Hamilton, ON, Canada, ³Queen’s School of Medicine, Kingston, Canada, ⁴Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA
Background/Purpose: COVID-19 has caused global disruptions in the management of chronic illnesses. The extent to which patients with rheumatic disease have been affected by COVID-19…
Abstract Number: 0614 • ACR Convergence 2020
Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey
Natllely Ruiz¹, José Enrique Ruiz Guizar², Erick A Zamora Tehozol³, Iris Jazmín Colunga Pedraza⁴, Cristina Hernández-Díaz⁵, Vijaya Rivera-Terán⁶, Cesar Pacheco Tena⁷ and Deshire Alpizar-Rodriguez⁶, ¹Instituto Nacional de Enfermedades Respiratorias, Mexico City, Distrito Federal, Mexico, ²Independent, Mexico City, Distrito Federal, Mexico, ³Centro Médico Pensiones, Merida, Yucatan, Mexico, ⁴Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, ⁵Instituto Nacional de Rehabilitación, Mexico City, Distrito Federal, Mexico, ⁶Colegio Mexicano de Reumatología, Mexico City, Distrito Federal, Mexico, ⁷Universidad Autonoma de Chihuahua, Chihuahua, Chihuahua, Mexico
Background/Purpose: COVID-19 pandemic is an evident challenge for healthcare systems and daily clinical practice in developing countries. Particularly, chronic diseases attention has faced difficulties. The…
Abstract Number: 0615 • ACR Convergence 2020
Rheumatology Going Digital: Developing a Rheumatology App for Use by All Patients Attending Our Department to Aid Remote Working and Self-management
Kirsten Mackay¹, Mark Clemence¹ and Rian Penford¹, ¹Torbay and South Devon NHS Foundation Trust, Torquay, United Kingdom
Background/Purpose: Patients with a rheumatological condition require information regarding the disease itself and treatments regimes. This is particularly important for new patients.Our local patient focus…
Abstract Number: 0616 • ACR Convergence 2020
Correlation Between Disease Activity and Perceived Economic Barriers to Care in a Population of African American Women with Systemic Lupus Erythematosus
Ashley White¹, Trevor Faith¹, Aissatou Ba¹, Viswanathan Ramakrishnan², Hetlena Johnson³, Jillian Rose⁴, Clara Dismuke-Greer⁵, Jim Oates⁶, Leonard Egede⁷ and Edith Williams¹, ¹Medical University of South Carolina, Charleston, SC, ²medical university of south carolina, south carolina, ³LupusCSC, Columbia, SC, ⁴Hospital for Special Surgery, New York, ⁵Palo Alto VA, Palo Alto, CA, ⁶Medical University of South Carolina, Charleston, SC, Charleston, SC, ⁷Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a complex, multifactorial disease with heterogeneous presentation. Disease activity – the number and severity of symptoms – can be…
Abstract Number: 0617 • ACR Convergence 2020
Support Methodologies for African American Women with Lupus – Comparing Two Study’s Effects on Patient Activation
Ashley White¹, Trevor Faith¹, Aissatou Ba¹, Viswanathan Ramakrishnan², Hetlena Johnson³, Jillian Rose⁴, Clara Dismuke-Greer⁵, Jim Oates⁶, Leonard Egede⁷ and Edith Williams¹, ¹Medical University of South Carolina, Charleston, SC, ²medical university of south carolina, south carolina, ³LupusCSC, Columbia, SC, ⁴Hospital for Special Surgery, New York, ⁵Palo Alto VA, Palo Alto, CA, ⁶Medical University of South Carolina, Charleston, SC, Charleston, SC, ⁷Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease in which the immune system of affected individuals attacks their own healthy tissues. While pharmaceutical…
Abstract Number: 0618 • ACR Convergence 2020
The Effect of Travel Burden on Depression and Anxiety in African American Women Living with Systemic Lupus
Trevor Faith¹, Ashley White¹, Aissatou Ba¹, Viswanathan Ramakrishnan², Hetlena Johnson³, Jillian Rose⁴, Clara Dismuke-Greer⁵, Jim Oates⁶, Leonard Egede⁷ and Edith Williams¹, ¹Medical University of South Carolina, Charleston, SC, ²medical university of south carolina, south carolina, ³LupusCSC, Columbia, SC, ⁴Hospital for Special Surgery, New York, ⁵Palo Alto VA, Palo Alto, CA, ⁶Medical University of South Carolina, Charleston, SC, Charleston, SC, ⁷Medical College of Wisconsin, Milwaukee, WI
Background/Purpose: The United States has a deficit of rheumatology specialists. This leads to an increased burden accessing care for patients with autoimmune and connective tissue…
Abstract Number: 0619 • ACR Convergence 2020
Pharmacist Intervention: Reducing Insurance Denials of Specialty Medications
Nisha Sharma¹, Nicole Girardi¹ and Karen Wong¹, ¹Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: Insurance companies have inconsistent formularies that do not align with Rheumatology clinical treatment guidelines. We are faced with the ongoing challenge of insurance companies…
Abstract Number: 0620 • ACR Convergence 2020
Do Physical Therapists Follow Evidence-Based Practice Recommendations for Treatment of Inflammatory Arthritides?
Debbie Ehrmann Feldman¹, Tatiana Orozco¹, Sasha Bernatsky², François Desmeules¹, Maude Laliberté³, Kadija Perreault⁴, Jonathan El-Khoury⁵, Jean Légaré⁴ and Linda Woodhouse⁶, ¹Université de Montréal, Montreal, QC, Canada, ²The Research Institute of the McGill University Health Centre, Montreal, ON, Canada, ³Integrated Health and Social Services University Network for West-Central Montreal, Montreal, Canada, ⁴Université Laval, Québec, QC, Canada, ⁵Université de Sherbrooke, Montreal, QC, Canada, ⁶Curtin University, Perth, Australia
Background/Purpose: Physical therapy plays an important role in the global management of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Therapeutic exercises (mobility, strength and aerobic)…
Abstract Number: 0621 • ACR Convergence 2020
Effectiveness of Screening in Patients with Rheumatic Disease Before Commencing Biologic Therapy and Risk of Active Tuberculosis
Sultana Abdulaziz¹, Suzan Attar², Wael Bajhammoh³, Eman Alsindi³, Eman Bakhashwain⁴ and Doaa Ayish⁵, ¹King Fahd Hospital, Jeddah, Saudi Arabia, ²King Abdulaziz University, Jeddah, Saudi Arabia, ³King Fahad Hospital, Jeddah, Saudi Arabia, ⁴East Jeddah Hospital, Jeddah, Saudi Arabia, ⁵Prince Mohammed Bin Nasser Hospital, Gizan, Saudi Arabia
Background/Purpose: Treatment with biologic therapy has been associated with a high risk of reactivation of latent tuberculosis (TB ). Preventive strategies for tuberculosis remain a…
Abstract Number: 0622 • ACR Convergence 2020
Infection-induced MPO-ANCA Associated Vasculitis: A Systematic Review of Published Case Reports
Konstantinos Parperis¹, Loukas Kakoullis², Eleni Papachristodoulou³ and George Panos³, ¹University of Arizona College of Medicine Phoenix and University of Cyprus Medical School, Phoenix, ²University of Patras School of Health Sciences, Patras, Akhaia, Greece, ³University of Cyprus Medical School, Nicosia, Nicosia, Cyprus
Background/Purpose: Anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA) has been implicated in the pathogenesis of microscopic polyangiitis (MPA) and an MPO-ANCA associated glomerulonephritis; both conditions are…
Abstract Number: 0623 • ACR Convergence 2020
Cytokine Storm: Outcomes in SARS-CoV-2 Patients Treated with Biologics in a Rheumatology Cohort
Neha Chiruvolu¹, Muntarin Karim², Patil Injean³, Sandy Lee³, Karina Torralba⁴, Christina Downey³, Mehrnaz Hojjati⁵, Loomee Doo⁵, Donna Jose⁶, Deepa Panikkath³, Micah Yu⁵, Anna Lafian⁵, Marven Cabling⁵ and Vaneet Sandhu⁷, ¹UC Riverside School of Medicine, Riverside, CA, ²Loma Linda University Health System, Loma Linda, CA, ³Loma Linda University Medical Center, Redlands, CA, ⁴Loma Linda University School of Medicine, Redlands, CA, ⁵Loma Linda University Medical Center, Loma Linda, CA, ⁶Loma Linda University Medical Center, Ontario, CA, ⁷Loma Linda University, Loma Linda, CA
Background/Purpose: Cytokine Release Syndrome (CRS) or Macrophage Activation Syndrome (MAS) is a life threating hyperinflammatory condition that can complicate rheumatic disease as well as infections…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].